Respiratory Diseases Respiratory Diseases We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in respiratory diseases.
Technologies Technologies We are expanding our global network of technology partners Learn more about partnering with us.
Cardiometabolic Diseases Cardiometabolic Diseases We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in CardioMetabolic diseases.
Zongertinib (BI 1810631): HER2 Tyrosine Kinase Inhibitor (TKI) | NSCLC Zongertinib (BI 1810631): HER2 Tyrosine Kinase Inhibitor (TKI) | NSCLC Zongertinib (BI 1810631): HER2 Tyrosine Kinase Inhibitor (TKI) | NSCLC
Five ways to include more diversity in clinical trials Five ways to include more diversity in clinical trials
Animal Health Partnering Interests Infectious Diseases May 2024 CORP Animal Health Partnering Interests Infectious Diseases May 2024 CORP
Animal Health Partnering Interests Pain & Mobility May 2024 CORP Animal Health Partnering Interests Pain & Mobility May 2024 CORP
Animal Health Partnering Interests Immunology & Inflammation May 2024 CORP Animal Health Partnering Interests Immunology & Inflammation May 2024 CORP
2024 MORE GREEN infographic - Environmental Stewardship at Boehringer Ingelheim 2024 MORE GREEN infographic - Environmental Stewardship at Boehringer Ingelheim
Defining underserved communities_Infographic_230627.pdf Defining underserved communities_Infographic_230627.pdf
Boehringer Ingelheim - Whitepaper High throughput cultivation platform microbial strain and process development Boehringer Ingelheim - Whitepaper High throughput cultivation platform microbial strain and process development
Partnering in Infectious Diseases MAY 2024 CORP_0.pdf Partnering in Infectious Diseases MAY 2024 CORP_0.pdf
Partnering with Boehringer Ingelheim MAY 2023 Corp Partnering with Boehringer Ingelheim MAY 2023 Corp
Defining underserved communities_Infographic_230627.pdf Defining underserved communities_Infographic_230627.pdf
Infographic_Defining underserved communities_230627.pdf Infographic_Defining underserved communities_230627.pdf
Partnering in Immunology & Inflammation MAY 2024 CORP_0.pdf Partnering in Immunology & Inflammation MAY 2024 CORP_0.pdf
Boehringer Ingelheim Animal Health Business Unit Factsheet_2.pdf Boehringer Ingelheim Animal Health Business Unit Factsheet_2.pdf